Section Arrow
Quote
GRDX.NASDAQ
- GridAI Technologies Corp
Quotes are at least 15-min delayed:2025/12/01 17:05 EST
After Hours
Last
 2.2139
-0.2661 (-10.73%)
Bid
2.2
Ask
2.49
High 2.48 
Low 2.21 
Volume 8 
Regular Hours (Closed)
Last
 2.48
-0.51 (-17.06%)
Day High 
2.75 
Prev. Close
2.99 
1-M High
-- 
Volume 
93.66K 
Bid
2.2
Ask
2.49
Day Low
2.305 
Open
2.55 
1-M Low
-- 
Market Cap 
10.05M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High -- 
52-W Low -- 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-12.57/-1.74
Enterprise Value
10.11M
Balance Sheet
Book Value Per Share
6.72
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
KALAKala BIO1.33+0.3639+37.67%-- 
After Hours 1.1901 -0.1399 -10.52%
QTTBQ32 Bio3.82+1.63+74.43%-- 
After Hours 3.95 +0.13 +3.40%
IBRXImmunityBio2.3-0.06-2.54%-- 
After Hours 2.32 +0.02 +0.87%
RXRXRecursion Pharmaceuticals4.36-0.27-5.83%-- 
After Hours 4.375 +0.015 +0.34%
IOVAIovance Biotherapeutics2.23-0.24-9.72%-- 
After Hours 2.2399 +0.0099 +0.44%
Industry overview quotes are at least 15 minutes delayed
Business Description
Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.